D-Wave Quantum Gains Nvidia's NVQLink Tailwind Ahead Of Q3 ER (Rating Upgrade) — Positive
NVDA QBTS Seeking Alpha — October 29, 2025D-Wave Computing (QBTS) is upgraded to Buy, driven by positive quantum sector developments and Nvidia's NVQLink announcement. QBTS stands out for commercial viability, rapid revenue growth, and a unique quantum annealing approach, differentiating it from peers like IonQ and Rigetti. Nvidia's NVQLink is seen as a major catalyst for QBTS, potentially accelerating demand and bridging the gap between quantum and classical computing.
ATKORE INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Atkore Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm — Neutral
ATKR GlobeNewsWire — October 29, 2025Allegedly, defendants hid Atkore's PVC pipe price-fixing scheme, which inflated profits until exposed, harming the Company's business and operations.
Amazon launches AI infrastructure project, to power Anthropic's Claude model — Positive
AMZN Reuters — October 29, 2025Amazon.com said on Wednesday it has launched its compute cluster project called Rainier, and added that artificial intelligence firm Anthropic will use more than a million chips of the infrastructure by the end of the year.
The company pushed back the first delivery of its new 777X model to 2027, citing regulatory hangups.
Here are the key Tesla shareholders backing Elon Musk's $1 trillion pay package — and who's against — Neutral
TSLA Business Insider — October 29, 2025Tesla shareholders are set to vote on Elon Musk's $1 trillion pay plan on November 6. Proxy firms have criticized the massive pay package, leading Musk to brand them "corporate terrorists.
Otis Worldwide (OTIS) Beats Q3 Earnings and Revenue Estimates — Positive
OTIS Zacks Investment Research — October 29, 2025Otis Worldwide (OTIS) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $0.96 per share a year ago.
Avantor, Inc. (AVTR) Q3 Earnings and Revenues Miss Estimates — Negative
AVTR Zacks Investment Research — October 29, 2025Avantor, Inc. (AVTR) came out with quarterly earnings of $0.22 per share, missing the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.26 per share a year ago.
TE Connectivity (TEL) Q4 Earnings and Revenues Beat Estimates — Positive
TEL Zacks Investment Research — October 29, 2025TE Connectivity (TEL) came out with quarterly earnings of $2.44 per share, beating the Zacks Consensus Estimate of $2.29 per share. This compares to earnings of $1.95 per share a year ago.
Blue Foundry Bancorp Reports Third Quarter 2025 Results — Neutral
BLFY GlobeNewsWire — October 29, 2025RUTHERFORD, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Blue Foundry Bancorp (NASDAQ:BLFY) (the “Company”), the holding company for Blue Foundry Bank (the “Bank”), today reported a net loss of $1.9 million, or $0.10 per diluted common share, for the three months ended September 30, 2025, compared to net loss of $2.0 million, or $0.10 per diluted common share, for the three months ended June 30, 2025, and a net loss of $4.0 million, or $0.19 per diluted common share, for the three months ended September 30, 2024.
IOVANCE INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Continues Investigation on Behalf of Long-Term Iovance, Inc. Stockholders — Neutral
IOVA GlobeNewsWire — October 29, 2025Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Iovance (IOVA) To Contact Him Directly To Discuss Their Options If you are a long-term stockholder in Iovance between May 9, 2024 and May 8, 2025 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Marion Passmore directly at (212) 355-4648.
ConocoPhillips: Adapting To Oil Market Headwinds While Unlocking Future Growth Potential — Negative
COP Seeking Alpha — October 29, 2025ConocoPhillips is rated a Buy, offering strong growth potential via major projects and recent Marathon Oil acquisition synergies. COP is adapting to lower oil prices with significant cost cuts, reduced CapEx guidance, and a major workforce reduction to preserve cash flow. Dividend yield is moderate, while buybacks are potentially unsustainable if oil prices remain low, with past precedent for dividend cuts during downturns.
UNIVERSAL THEME PARKS: THE EXHIBITION TICKETS ON SALE NOW FOR THE WORLD PREMIERE AT THE FRANKLIN INSTITUTE — Neutral
CMCSA PRNewsWire — October 29, 2025OPENS FEBRUARY 14, 2026, IN PARTNERSHIP WITH COMCAST NBCUNIVERSAL FIRST LOOK AT NEW RENDERINGS AND EXHIBIT ART! PHILADELPHIA , Oct. 29, 2025 /PRNewswire/ -- Tickets are now on sale for the world premiere of Universal Theme Parks: The Exhibition, opening February 14, 2026, at The Franklin Institute in partnership with Comcast NBCUniversal.
The company pushed back the first delivery of its new 777X model to 2027, citing regulatory hangups.
Etsy stock sinks on CEO change — Silverman stepping down, Depop chief to take over — Negative
ETSY CNBC — October 29, 2025Etsy said Josh Silverman will step down as CEO and be replaced by Depop chief Kruti Patel Goyal. In this article ETSY
JAMF Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Jamf Holding Corp. is Fair to Shareholders — Neutral
JAMF Business Wire — October 29, 2025NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Jamf Holding Corp. (NASDAQ: JAMF) to Francisco Partners for $13.05 per share is fair to Jamf shareholders. Halper Sadeh encourages Jamf shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. The investigation concerns whether Jamf and its board of dire.
AbbVie Announces Positive Topline Results from Phase 3 Pivotal Studies Evaluating Upadacitinib (RINVOQ®) in Adults and Adolescents with Vitiligo — Neutral
ABBV PRNewsWire — October 29, 2025In two replicate Phase 3 studies, upadacitinib (RINVOQ ® ) achieved the co-primary endpoints of 50% reduction in Total Vitiligo Area Scoring Index (T-VASI 50) from baseline and 75% reduction in Facial Vitiligo Area Scoring Index (F-VASI 75) from baseline at week 481 Both studies met key ranked secondary endpoints1 NORTH CHICAGO, Ill. , Oct. 29, 2025 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced positive topline results from two replicate Phase 3 studies evaluating the safety and efficacy of upadacitinib (RINVOQ®;15 mg, once daily in adult and adolescent patients living with non-segmental vitiligo (NSV).1 NSV, the most common form of …
Centene (CNC) Surpasses Q3 Earnings and Revenue Estimates — Positive
CNC Zacks Investment Research — October 29, 2025Centene (CNC) came out with quarterly earnings of $0.5 per share, beating the Zacks Consensus Estimate of a loss of $0.21 per share. This compares to earnings of $1.62 per share a year ago.
Generac Holdings (GNRC) Q3 Earnings and Revenues Lag Estimates — Negative
GNRC Zacks Investment Research — October 29, 2025Generac Holdings (GNRC) came out with quarterly earnings of $1.83 per share, missing the Zacks Consensus Estimate of $2.25 per share. This compares to earnings of $2.25 per share a year ago.
SiteOne Landscape (SITE) Beats Q3 Earnings and Revenue Estimates — Positive
SITE Zacks Investment Research — October 29, 2025SiteOne Landscape (SITE) came out with quarterly earnings of $1.31 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $0.97 per share a year ago.